When liver disease comes to mind, many are more familiar with the types that occur in heavy drinkers of alcohol or from hepatitis C. On the contrary, the most common chronic liver condition in Western populations is non-alcoholic fatty liver disease (NAFLD). NAFLD affects people who drink little to no alcohol but face the same …
The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.
If you or someone you know is diagnosed with diabetes you may qualify for upcoming clinical trials. Learn more about getting involved today.
Local physicians are looking for volunteers who are overweight to participate in upcoming clinical trials.
If you or someone you know is struggling with hernia pain you may qualify for an upcoming clinical research trial enrolling now.
